Physician

Brandon Ross, M.D.

According to 2025 Medicare claims, Brandon Ross, M.D. (NPI: 1154327252) practices allergy/immunology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is BRANDON ROSS MD PC (NPI: 1508045386; TIN: 383331975) and primary practice location at 48085-7008. Ross is affiliated with the POM ACO (ACO ID: A1297), participating under the MSSP model.

Ross' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 87 traditional Medicare patients, billed 1,598 HCPCS/CPT codes, and received $21,663 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 658 prescription claims across 138 beneficiaries totaling $230,563 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). 2020 DME data shows 17 claims. Open Payments data shows 6 records totaling $131. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $94,207 to $230,563. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $444 to $246.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	114	1,454	$20,263
2016	121	1,715	$23,655
2017	110	1,786	$26,240
2018	126	2,251	$28,556
2019	117	2,046	$27,394
2020	108	1,495	$20,869
2021	111	1,937	$27,351
2022	79	1,248	$19,018
2023	93	1,505	$22,354
2024	87	1,598	$21,663

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	131	709	$94,207
2016	134	765	$110,750
2017	137	801	$142,279
2018	134	792	$173,537
2019	136	783	$151,582
2020	123	736	$170,454
2021	146	600	$172,476
2022	124	645	$156,360
2023	117	559	$143,943
2024	138	658	$230,563

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	22	$168
2016	N/R	45	$651
2017	N/R	27	$484
2018	N/R	14	$60
2019	N/R	11	$259
2020	N/R	17	$57
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	32	44	$101
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	59	80	$69
94010	Test to measure expiratory airflow and volume	27	28	$21
95165	Professional service for preparation and provision of 1 or more antigens	20	300	$9
95117	Professional service for multiple injections of allergen	21	217	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	45	2,190	$43,872
Breo Ellipta	Fluticasone/Vilanterol	30	1,650	$20,386
Arnuity Ellipta	Fluticasone Furoate	44	1,920	$13,992
Xhance	Fluticasone Propionate	12	360	$7,986
Symbicort	Budesonide/Formoterol Fumarate	20	1,080	$7,927

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$131	Nalu Medical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brandon Ross, M.D.?

Tedicare shows public-source Medicare data for Brandon Ross, M.D. (NPI 1154327252), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brandon Ross, M.D. have ACO affiliation data?

Brandon Ross, M.D. is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297).

What billing organization is linked to Brandon Ross, M.D.?

Brandon Ross, M.D. is linked to BRANDON ROSS MD PC (billing NPI 1508045386) in the available physician profile data.

Does Brandon Ross, M.D. have Open Payments data?

Brandon Ross, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.